Integrated proteomic and targeted Next Generation Sequencing reveal relevant heterogeneity in lower-grade meningioma and ANXA3 as a new target in NF2 mutated meningiomas
Authors
Leandro José de Assis (ORCID: https://orcid.org/0000-0001-9782-437X)
Integrated proteomic and targeted Next Generation Sequencing reveal relevant heterogeneity in lower-grade meningioma and ANXA3 as a new target in NF2 mutated meningiomas
Leandro José de Assis, Emanuela Ercolano, Claire Adams, Maryam Shah et al.
Journal
EBioMedicine
Topics
Meningioma and schwannoma management
article
Integrated proteomic and targeted Next Generation Sequencing reveal relevant heterogeneity in lower-grade meningioma and ANXA3 as a new target in NF2 mutated meningiomas
Leandro José de Assis, Emanuela Ercolano, Claire Adams, Maryam Shah, Liyam Laraba, C. Oliver Hanemann, Kathreena M. Kurian, David B. Parkinson, Matthew C. Banton, Waldemar Woznica, Vikram Sharma, David A. Hilton, Yeasmin Akther
article en
Abstract
No abstract available for this paper.
Publication Tag
EBioMedicineVol. 117
Institutions
North Bristol NHS Trust (GB), Southmead Hospital (GB), Derriford Hospital (GB), University Hospitals Plymouth NHS Trust (GB), Peninsula College of Medicine and Dentistry (GB), University of Plymouth (GB)
Funders
British Neuropathological Society, Brain Tumour Research, Medical Research Council